Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324475PMC
http://dx.doi.org/10.1038/s41375-021-01128-1DOI Listing

Publication Analysis

Top Keywords

sensitive gata1
4
gata1 mutation
4
mutation screening
4
screening reliably
4
reliably identifies
4
identifies neonates
4
neonates syndrome
4
syndrome risk
4
risk myeloid
4
myeloid leukemia
4

Similar Publications

Myelodysplastic syndrome (MDS) is a group of blood disorders characterized by impaired maturation of erythroid cells. Mutations in the U2 small nuclear RNA auxiliary factor 1 (U2AF1) gene, particularly S34 (S34F/Y) and Q157 (Q157P/R), have been identified in 5-10% of MDS patients. By analyzing U2AF1 expression in hematopoietic stem progenitor cells and different blood cells in the GEO database, we have found the expression pattern of U2AF1 showed a significant stage specificity during normal erythropoiesis.

View Article and Find Full Text PDF

Objectives: Diffuse large B-cell lymphoma (DLBCL) is a common and highly aggressive type of lymphoma. Iron metabolism plays a critical role in human diseases, however, which remains unclear in DLBCL patients. The study is to explore the genetic characteristics and molecular mechanisms underlying ferroptosis in DLBCL patients.

View Article and Find Full Text PDF

The causal association between pulmonary arterial hypertension (PAH) and autoimmune diseases remains uncertain. This study aimed to assess the causal associations between PAH and autoimmune diseases using bidirectional Mendelian randomization (MR) analyses. Genome-wide association summary statistics for PAH, asthma, myasthenia gravis, rheumatoid arthritis (RA), systemic lupus erythematosus, and type 1 diabetes mellitus were obtained from publicly accessible databases.

View Article and Find Full Text PDF

Unlabelled: Patients with Acute Myeloid Leukemia (AML) subtypes, acute erythroleukemia and acute megakaryocytic leukemia (M6 and M7 AMLs, respectively) have a median survival of only a few months with no targeted effective treatment. Our gene expression analysis using the Cancer Cell Line Encyclopedia and CRISPR screen from DepMap showed that M6/M7 AMLs have high levels of the transcription factor and depend on GATA1 for survival. While GATA1 was shown to support AML cell proliferation and resistance to chemotherapy, GATA1 has long been considered "undruggable".

View Article and Find Full Text PDF

Identification of Potential Crucial Biomarkers in STEMI Through Integrated Bioinformatic Analysis.

Arq Bras Cardiol

April 2024

Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing - China.

Article Synopsis
  • The study investigates potential biomarkers for ST-segment elevation myocardial infarction (STEMI), a major cause of cardiovascular mortality.
  • A bioinformatics analysis identified 133 differentially expressed genes (DEGs) that highlight the roles of inflammation, metabolism, and immunity in the progression from stable coronary artery disease (SCAD) to STEMI.
  • Specific genes MS4A3, KLRC4, KLRD1, AQP9, and CD14 showed promise as candidate biomarkers due to their high sensitivity and specificity in predicting STEMI.
View Article and Find Full Text PDF